IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal

RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets hi...

Full description

Saved in:
Bibliographic Details
Published inCirculation research Vol. 111; no. 8; pp. 1054 - 1064
Main Authors Sun, Chongxiu, Alkhoury, Kenan, Wang, Ying I., Foster, Greg A., Radecke, Christopher E., Tam, Kayan, Edwards, Christina M., Facciotti, Marc T., Armstrong, Ehrin J., Knowlton, Anne A., Newman, John W., Passerini, Anthony G., Simon, Scott I.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD American Heart Association, Inc 28.09.2012
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect. OBJECTIVE:We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal. METHODS AND RESULTS:Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1. CONCLUSIONS:In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.
AbstractList A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect.RATIONALEA high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect.We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal.OBJECTIVEWe investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal.Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1.METHODS AND RESULTSPostprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1.In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.CONCLUSIONSIn response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.
A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect. We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal. Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1. In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.
RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect. OBJECTIVE:We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal. METHODS AND RESULTS:Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1. CONCLUSIONS:In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.
Author Wang, Ying I.
Radecke, Christopher E.
Armstrong, Ehrin J.
Edwards, Christina M.
Foster, Greg A.
Alkhoury, Kenan
Facciotti, Marc T.
Newman, John W.
Passerini, Anthony G.
Knowlton, Anne A.
Simon, Scott I.
Sun, Chongxiu
Tam, Kayan
AuthorAffiliation From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.)
AuthorAffiliation_xml – name: From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.)
– name: 5 Obesity and Metabolism Research Unit, USDA-ARS- Western Human Nutrition Research Center, Davis, CA
– name: 2 Division of Cardiovascular Medicine, University of California Davis, Davis CA
– name: 3 Departments of Medicine and Pharmacology, University of California Davis, Davis CA
– name: 4 Department of Nutrition, University of California Davis, Davis CA
– name: 1 Department of Biomedical Engineering, University of California Davis, Davis CA
Author_xml – sequence: 1
  givenname: Chongxiu
  surname: Sun
  fullname: Sun, Chongxiu
  organization: From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.)
– sequence: 2
  givenname: Kenan
  surname: Alkhoury
  fullname: Alkhoury, Kenan
– sequence: 3
  givenname: Ying
  surname: Wang
  middlename: I.
  fullname: Wang, Ying I.
– sequence: 4
  givenname: Greg
  surname: Foster
  middlename: A.
  fullname: Foster, Greg A.
– sequence: 5
  givenname: Christopher
  surname: Radecke
  middlename: E.
  fullname: Radecke, Christopher E.
– sequence: 6
  givenname: Kayan
  surname: Tam
  fullname: Tam, Kayan
– sequence: 7
  givenname: Christina
  surname: Edwards
  middlename: M.
  fullname: Edwards, Christina M.
– sequence: 8
  givenname: Marc
  surname: Facciotti
  middlename: T.
  fullname: Facciotti, Marc T.
– sequence: 9
  givenname: Ehrin
  surname: Armstrong
  middlename: J.
  fullname: Armstrong, Ehrin J.
– sequence: 10
  givenname: Anne
  surname: Knowlton
  middlename: A.
  fullname: Knowlton, Anne A.
– sequence: 11
  givenname: John
  surname: Newman
  middlename: W.
  fullname: Newman, John W.
– sequence: 12
  givenname: Anthony
  surname: Passerini
  middlename: G.
  fullname: Passerini, Anthony G.
– sequence: 13
  givenname: Scott
  surname: Simon
  middlename: I.
  fullname: Simon, Scott I.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26395633$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22874466$$D View this record in MEDLINE/PubMed
BookMark eNqFkV9v0zAUxS00xLrBRwD5BYmXDDtxnFhISFXU0kotSOHPq-XYN6vBjTs7YfDtMWrHgJc9WVf3d-6xzrlAZ4MfAKHnlFxRyunrZt027eLjfDVPc36VV6Sg7BGa0TJnGSsreoZmhBCRVUVBztFFjF8JoazIxRN0nud1xRjnM7RZt8uMYjUYvLft-znNOd56Mzk1Av7SzLdpufhxCBCj9QO2A24hHvwQAY8eK7yy17tsqUa8BeWeose9chGend5L9Hm5-NSsss2Hd-tmvsl0SQnLoNK0r0Qtur4WzPCSAy1VBXVlBPCKaSBGGVMIVppeM02rTkBfm7LrTK0ELS7R2-Pdw9TtwWgYxqCcPAS7V-Gn9MrKfzeD3clr_10WNSWUl-nAq9OB4G8miKPc26jBOTWAn6KkpKYpoZRzQl_87fXH5C7CBLw8ASpq5fqgBm3jPccLUfKiSNybI6eDjzFAL7Ud1ZhSTV-0LnnK38XK-2LTnMtjsUld_qe-M3hIJ466W-9GCPGbm24hyF1qa9w9oP0F8Q23QA
CODEN CIRUAL
CitedBy_id crossref_primary_10_1096_fj_14_260323
crossref_primary_10_1186_s12860_021_00345_x
crossref_primary_10_1002_stem_2193
crossref_primary_10_1016_j_jnutbio_2019_03_004
crossref_primary_10_1007_s10557_021_07168_0
crossref_primary_10_1016_j_lfs_2015_04_016
crossref_primary_10_1186_1471_2377_13_178
crossref_primary_10_1152_ajpheart_00411_2018
crossref_primary_10_1084_jem_20131125
crossref_primary_10_1097_SLA_0000000000001466
crossref_primary_10_1152_ajpheart_00311_2013
crossref_primary_10_1016_j_jnutbio_2015_07_012
crossref_primary_10_3389_fendo_2021_646233
crossref_primary_10_1038_s41598_019_45005_5
crossref_primary_10_1097_MOL_0000000000000108
crossref_primary_10_14336_AD_2021_0929
crossref_primary_10_3390_jcm8122199
crossref_primary_10_1186_s12944_017_0625_0
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106292
crossref_primary_10_3389_fmolb_2022_909151
crossref_primary_10_1007_s12031_013_0207_1
crossref_primary_10_1097_CRD_0000000000000114
crossref_primary_10_1007_s11883_022_00979_y
crossref_primary_10_1161_HYPERTENSIONAHA_115_04898
crossref_primary_10_1089_ars_2012_4803
crossref_primary_10_1016_j_mce_2017_05_039
crossref_primary_10_1097_HCO_0b013e3283606971
crossref_primary_10_3390_jfb16010002
crossref_primary_10_1177_20503121241272646
crossref_primary_10_1016_j_expneurol_2020_113382
crossref_primary_10_1111_cmi_12819
crossref_primary_10_1194_jlr_M067108
crossref_primary_10_1152_physiolgenomics_00106_2013
crossref_primary_10_1186_s13104_021_05700_x
crossref_primary_10_1055_a_1480_7692
crossref_primary_10_1161_ATVBAHA_115_306094
crossref_primary_10_1536_ihj_17_459
crossref_primary_10_1002_biof_1306
crossref_primary_10_1161_CIRCRESAHA_115_307674
crossref_primary_10_1007_s10753_024_02209_w
crossref_primary_10_3390_nu11061326
crossref_primary_10_3389_fcvm_2022_889743
crossref_primary_10_1016_j_plefa_2018_05_001
crossref_primary_10_3390_cells11040607
crossref_primary_10_1016_j_cpcardiol_2019_03_002
crossref_primary_10_1016_j_yjmcc_2016_12_005
crossref_primary_10_1016_j_biopha_2025_117953
crossref_primary_10_1016_j_lfs_2013_08_010
crossref_primary_10_1093_cvr_cvv192
crossref_primary_10_1080_07315724_2021_2025168
crossref_primary_10_1371_journal_pone_0215620
crossref_primary_10_18632_oncotarget_25542
crossref_primary_10_1146_annurev_bioeng_071813_104908
crossref_primary_10_1093_jn_nxaa003
crossref_primary_10_1080_21655979_2022_2063496
crossref_primary_10_1007_s10571_016_0331_x
crossref_primary_10_1167_iovs_18_25617
crossref_primary_10_1007_s12170_022_00702_1
crossref_primary_10_3389_fimmu_2022_1097409
crossref_primary_10_1007_s11883_013_0372_2
crossref_primary_10_18632_oncotarget_2280
crossref_primary_10_4049_jimmunol_2000485
crossref_primary_10_1111_ejn_12872
crossref_primary_10_1016_j_jacc_2014_09_042
crossref_primary_10_3390_pharmaceutics15051379
crossref_primary_10_1038_s41598_017_08417_9
crossref_primary_10_5301_heartint_5000226
crossref_primary_10_1016_j_jacbts_2022_08_002
crossref_primary_10_1161_JAHA_114_001249
crossref_primary_10_1080_01616412_2017_1327505
Cites_doi 10.1046/j.1365-2796.1999.00548.x
10.1194/jlr.M010371
10.1161/circulationaha.106.622514
10.1128/MCB.15.5.2558
10.1093/ajcn/83.2.456S
10.4049/jimmunol.180.11.7516
10.1073/pnas.0707493105
10.1161/01.ATV.21.3.407
10.1093/ajcn/81.1.25
10.1038/nri2156
10.1016/j.plefa.2007.10.004
10.1152/ajpheart.01036.2010
10.1084/jem.187.12.2023
10.4049/jimmunol.173.3.2041
10.1074/jbc.270.48.28903
10.1084/jem.176.6.1583
10.1161/atvbaha.110.211706
10.1016/j.jnutbio.2010.01.007
10.1161/01.res.0000258023.76515.a3
10.1021/ac050692f
10.1073/pnas.0538015100
10.1097/00007890-200005270-00030
10.1161/atvbaha.110.215434
10.1016/j.cell.2008.07.048
10.1016/S1097-2765(00)80467-0
10.1111/j.1365-2567.2008.02892.x
10.1016/j.metabol.2008.01.036
10.1042/BST0320994
10.1161/01.CIR.99.24.3125
10.1007/s00394-003-0408-4
10.1161/CIR.0b013e3182160726
10.1161/atvbaha.107.159228
10.1074/jbc.M109.044065
10.1093/ajcn/71.1.213S
10.1016/S0002-9149(96)00760-6
10.1194/jlr.M700505-JLR200
10.4049/jimmunol.0902369
10.1016/j.numecd.2008.07.008
ContentType Journal Article
Copyright 2012 American Heart Association, Inc.
2015 INIST-CNRS
Copyright_xml – notice: 2012 American Heart Association, Inc.
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1161/CIRCRESAHA.112.270314
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4571
EndPage 1064
ExternalDocumentID PMC3810165
22874466
26395633
10_1161_CIRCRESAHA_112_270314
10.1161/CIRCRESAHA.112.270314
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL077281
– fundername: NIAID NIH HHS
  grantid: R01 AI047294
– fundername: NCI NIH HHS
  grantid: P30 CA093373
– fundername: NHLBI NIH HHS
  grantid: R01 HL082689
– fundername: NHLBI NIH HHS
  grantid: HL082689
– fundername: NHLBI NIH HHS
  grantid: R01 HL077281
– fundername: NHLBI NIH HHS
  grantid: R01 HL079071
– fundername: NHLBI NIH HHS
  grantid: HL079071
– fundername: National Heart, Lung, and Blood Institute : NHLBI
  grantid: R01 HL082689 || HL
GroupedDBID ---
-~X
.-D
.3C
.55
.GJ
.Z2
01R
0R~
18M
1CY
1J1
29B
2WC
40H
41~
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACNWC
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C1A
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
MVM
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB2
OCUKA
ODA
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
ZFV
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c5104-e7c1f7989bf894d656e15a7e87d9e674ce0dadd3945dfc4c17b9ef8d5bbd8a913
ISSN 0009-7330
1524-4571
IngestDate Thu Aug 21 14:02:13 EDT 2025
Thu Jul 10 23:24:52 EDT 2025
Mon Jul 21 06:06:38 EDT 2025
Mon Jul 21 09:14:52 EDT 2025
Tue Jul 01 04:27:43 EDT 2025
Thu Apr 24 23:05:21 EDT 2025
Fri May 16 03:47:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Metabolic diseases
Cardiovascular disease
Lipids
Hyperlipoproteinemia
Lipoprotein
triglycerides
Triglyceride
Enzymopathy
Fatty acids
Vascular disease
Vertebrata
Mammalia
Hypertriglyceridemia
Atherosclerosis
Fat
Endothelial dysfunction
Circulatory system
Dyslipemia
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5104-e7c1f7989bf894d656e15a7e87d9e674ce0dadd3945dfc4c17b9ef8d5bbd8a913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22874466
PQID 1081874161
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3810165
proquest_miscellaneous_1081874161
pubmed_primary_22874466
pascalfrancis_primary_26395633
crossref_citationtrail_10_1161_CIRCRESAHA_112_270314
crossref_primary_10_1161_CIRCRESAHA_112_270314
wolterskluwer_health_10_1161_CIRCRESAHA_112_270314
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-09-28
PublicationDateYYYYMMDD 2012-09-28
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-28
  day: 28
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Circulation research
PublicationTitleAlternate Circ Res
PublicationYear 2012
Publisher American Heart Association, Inc
Lippincott Williams & Wilkins
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott Williams & Wilkins
References e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_41_2
e_1_3_4_6_2
e_1_3_4_40_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_22_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_21_2
e_1_3_4_26_2
e_1_3_4_27_2
e_1_3_4_24_2
e_1_3_4_25_2
e_1_3_4_28_2
e_1_3_4_29_2
Hart CM (e_1_3_4_32_2) 1991; 260
Grapov D (e_1_3_4_16_2)
e_1_3_4_30_2
e_1_3_4_11_2
e_1_3_4_34_2
e_1_3_4_12_2
e_1_3_4_33_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_15_2
e_1_3_4_38_2
e_1_3_4_37_2
e_1_3_4_13_2
e_1_3_4_36_2
e_1_3_4_14_2
e_1_3_4_35_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_18_2
e_1_3_4_39_2
7499419 - J Biol Chem. 1995 Dec 1;270(48):28903-9
19648648 - J Biol Chem. 2009 Oct 2;284(40):27384-92
20573493 - J Nutr Biochem. 2011 Feb;22(2):187-94
10583705 - J Intern Med. 1999 Oct;246(4):341-55
2058691 - Am J Physiol. 1991 Jun;260(6 Pt 1):L481-8
9625761 - J Exp Med. 1998 Jun 15;187(12):2023-30
18490752 - J Immunol. 2008 Jun 1;180(11):7516-24
18036803 - Prostaglandins Leukot Essent Fatty Acids. 2008 Jan;78(1):33-43
17717539 - Nat Rev Immunol. 2007 Sep;7(9):678-89
7537851 - Mol Cell Biol. 1995 May;15(5):2558-69
19949084 - J Immunol. 2010 Jan 1;184(1):21-5
22815358 - Bioinformatics. 2012 Sep 1;28(17):2288-90
10617974 - Am J Clin Nutr. 2000 Jan;71(1 Suppl):213S-23S
16159116 - Anal Chem. 2005 Sep 15;77(18):5870-6
18624726 - Immunology. 2009 Feb;126(2):233-45
15506945 - Biochem Soc Trans. 2004 Dec;32(Pt 6):994-8
15265939 - J Immunol. 2004 Aug 1;173(3):2041-9
21502576 - Circulation. 2011 May 24;123(20):2292-333
18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
20852092 - J Lipid Res. 2010 Dec;51(12):3470-80
1281211 - J Exp Med. 1992 Dec 1;176(6):1583-93
9036757 - Am J Cardiol. 1997 Feb 1;79(3):350-4
21169396 - Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H784-91
20671229 - Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1990-7
12923654 - Eur J Nutr. 2003 Aug;42(4):224-7
17234968 - Circ Res. 2007 Feb 16;100(3):381-90
16894036 - Circulation. 2006 Aug 15;114(7):681-7
10198642 - Mol Cell. 1999 Mar;3(3):397-403
16470012 - Am J Clin Nutr. 2006 Feb;83(2):456S-460S
18803934 - Metabolism. 2008 Oct;57(10):1328-39
21030716 - Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6
12606719 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2730-5
18812596 - J Lipid Res. 2009 Feb;50(2):204-13
10377075 - Circulation. 1999 Jun 22;99(24):3125-31
18805087 - Cell. 2008 Sep 19;134(6):933-44
18227515 - Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21
18804984 - Nutr Metab Cardiovasc Dis. 2009 May;19(4):264-70
11231921 - Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):407-14
15640456 - Am J Clin Nutr. 2005 Jan;81(1):25-34
10852612 - Transplantation. 2000 May 27;69(10):2131-7
References_xml – ident: e_1_3_4_2_2
  doi: 10.1046/j.1365-2796.1999.00548.x
– ident: e_1_3_4_31_2
  doi: 10.1194/jlr.M010371
– ident: e_1_3_4_16_2
  article-title: Imdev: a graphical user interface to r multivariate analysis tools in Microsoft Excel.
  publication-title: Bioinformatics
– ident: e_1_3_4_10_2
  doi: 10.1161/circulationaha.106.622514
– ident: e_1_3_4_38_2
  doi: 10.1128/MCB.15.5.2558
– ident: e_1_3_4_17_2
  doi: 10.1093/ajcn/83.2.456S
– ident: e_1_3_4_20_2
  doi: 10.4049/jimmunol.180.11.7516
– ident: e_1_3_4_22_2
  doi: 10.1073/pnas.0707493105
– ident: e_1_3_4_24_2
  doi: 10.1161/01.ATV.21.3.407
– ident: e_1_3_4_7_2
  doi: 10.1093/ajcn/81.1.25
– ident: e_1_3_4_11_2
  doi: 10.1038/nri2156
– ident: e_1_3_4_36_2
  doi: 10.1016/j.plefa.2007.10.004
– ident: e_1_3_4_13_2
  doi: 10.1152/ajpheart.01036.2010
– ident: e_1_3_4_21_2
  doi: 10.1084/jem.187.12.2023
– ident: e_1_3_4_15_2
  doi: 10.4049/jimmunol.173.3.2041
– ident: e_1_3_4_39_2
  doi: 10.1074/jbc.270.48.28903
– ident: e_1_3_4_19_2
  doi: 10.1084/jem.176.6.1583
– ident: e_1_3_4_41_2
  doi: 10.1161/atvbaha.110.211706
– ident: e_1_3_4_37_2
  doi: 10.1016/j.jnutbio.2010.01.007
– ident: e_1_3_4_12_2
  doi: 10.1161/01.res.0000258023.76515.a3
– ident: e_1_3_4_6_2
  doi: 10.1021/ac050692f
– ident: e_1_3_4_25_2
  doi: 10.1073/pnas.0538015100
– ident: e_1_3_4_40_2
  doi: 10.1097/00007890-200005270-00030
– ident: e_1_3_4_14_2
  doi: 10.1161/atvbaha.110.215434
– ident: e_1_3_4_30_2
  doi: 10.1016/j.cell.2008.07.048
– volume: 260
  start-page: L481
  year: 1991
  ident: e_1_3_4_32_2
  article-title: Supplemental fatty acids alter lipid peroxidation and oxidant injury in endothelial cells.
  publication-title: Am J Physiol
– ident: e_1_3_4_26_2
  doi: 10.1016/S1097-2765(00)80467-0
– ident: e_1_3_4_29_2
  doi: 10.1111/j.1365-2567.2008.02892.x
– ident: e_1_3_4_34_2
  doi: 10.1016/j.metabol.2008.01.036
– ident: e_1_3_4_8_2
  doi: 10.1042/BST0320994
– ident: e_1_3_4_28_2
  doi: 10.1161/01.CIR.99.24.3125
– ident: e_1_3_4_33_2
  doi: 10.1007/s00394-003-0408-4
– ident: e_1_3_4_3_2
  doi: 10.1161/CIR.0b013e3182160726
– ident: e_1_3_4_5_2
  doi: 10.1161/atvbaha.107.159228
– ident: e_1_3_4_27_2
  doi: 10.1074/jbc.M109.044065
– ident: e_1_3_4_18_2
  doi: 10.1093/ajcn/71.1.213S
– ident: e_1_3_4_4_2
  doi: 10.1016/S0002-9149(96)00760-6
– ident: e_1_3_4_9_2
  doi: 10.1194/jlr.M700505-JLR200
– ident: e_1_3_4_23_2
  doi: 10.4049/jimmunol.0902369
– ident: e_1_3_4_35_2
  doi: 10.1016/j.numecd.2008.07.008
– reference: 17717539 - Nat Rev Immunol. 2007 Sep;7(9):678-89
– reference: 2058691 - Am J Physiol. 1991 Jun;260(6 Pt 1):L481-8
– reference: 20671229 - Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1990-7
– reference: 15506945 - Biochem Soc Trans. 2004 Dec;32(Pt 6):994-8
– reference: 7537851 - Mol Cell Biol. 1995 May;15(5):2558-69
– reference: 10377075 - Circulation. 1999 Jun 22;99(24):3125-31
– reference: 10583705 - J Intern Med. 1999 Oct;246(4):341-55
– reference: 21169396 - Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H784-91
– reference: 19648648 - J Biol Chem. 2009 Oct 2;284(40):27384-92
– reference: 18812596 - J Lipid Res. 2009 Feb;50(2):204-13
– reference: 18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
– reference: 18804984 - Nutr Metab Cardiovasc Dis. 2009 May;19(4):264-70
– reference: 21502576 - Circulation. 2011 May 24;123(20):2292-333
– reference: 18805087 - Cell. 2008 Sep 19;134(6):933-44
– reference: 11231921 - Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):407-14
– reference: 19949084 - J Immunol. 2010 Jan 1;184(1):21-5
– reference: 20852092 - J Lipid Res. 2010 Dec;51(12):3470-80
– reference: 16894036 - Circulation. 2006 Aug 15;114(7):681-7
– reference: 18490752 - J Immunol. 2008 Jun 1;180(11):7516-24
– reference: 21030716 - Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6
– reference: 10198642 - Mol Cell. 1999 Mar;3(3):397-403
– reference: 9625761 - J Exp Med. 1998 Jun 15;187(12):2023-30
– reference: 15265939 - J Immunol. 2004 Aug 1;173(3):2041-9
– reference: 16159116 - Anal Chem. 2005 Sep 15;77(18):5870-6
– reference: 18803934 - Metabolism. 2008 Oct;57(10):1328-39
– reference: 10617974 - Am J Clin Nutr. 2000 Jan;71(1 Suppl):213S-23S
– reference: 20573493 - J Nutr Biochem. 2011 Feb;22(2):187-94
– reference: 22815358 - Bioinformatics. 2012 Sep 1;28(17):2288-90
– reference: 17234968 - Circ Res. 2007 Feb 16;100(3):381-90
– reference: 12606719 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2730-5
– reference: 1281211 - J Exp Med. 1992 Dec 1;176(6):1583-93
– reference: 9036757 - Am J Cardiol. 1997 Feb 1;79(3):350-4
– reference: 18036803 - Prostaglandins Leukot Essent Fatty Acids. 2008 Jan;78(1):33-43
– reference: 10852612 - Transplantation. 2000 May 27;69(10):2131-7
– reference: 12923654 - Eur J Nutr. 2003 Aug;42(4):224-7
– reference: 7499419 - J Biol Chem. 1995 Dec 1;270(48):28903-9
– reference: 18624726 - Immunology. 2009 Feb;126(2):233-45
– reference: 15640456 - Am J Clin Nutr. 2005 Jan;81(1):25-34
– reference: 18227515 - Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21
– reference: 16470012 - Am J Clin Nutr. 2006 Feb;83(2):456S-460S
SSID ssj0014329
Score 2.3838494
Snippet RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process...
A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1054
SubjectTerms Aorta - cytology
Atherosclerosis (general aspects, experimental research)
Atherosclerosis - genetics
Atherosclerosis - metabolism
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cell Adhesion - physiology
Cell Line
Dietary Fats - administration & dosage
Dietary Fats, Unsaturated - administration & dosage
Disorders of blood lipids. Hyperlipoproteinemia
Endothelial Cells - cytology
Endothelial Cells - physiology
Fundamental and applied biological sciences. Psychology
Humans
Hypertriglyceridemia - genetics
Hypertriglyceridemia - metabolism
Interferon Regulatory Factor-1 - genetics
Interferon Regulatory Factor-1 - metabolism
Medical sciences
Metabolic diseases
MicroRNAs - physiology
Monocytes - metabolism
NF-kappa B - metabolism
Postprandial Period - physiology
Protein Processing, Post-Translational - physiology
Transcription Factor AP-1 - metabolism
Tumor Necrosis Factor-alpha - metabolism
Vascular Cell Adhesion Molecule-1 - genetics
Vascular Cell Adhesion Molecule-1 - metabolism
Vertebrates: cardiovascular system
Title IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal
URI https://www.ncbi.nlm.nih.gov/pubmed/22874466
https://www.proquest.com/docview/1081874161
https://pubmed.ncbi.nlm.nih.gov/PMC3810165
Volume 111
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBDShLgTLpOReKtS6tRxkseoWulQW6TSQnmKEsdh1dZkWhMx8es5duykFRUMXqLWqXPp9_n4-PhcEHpHWTxwYy53GFnfptIpxxeM2CkRjidThPUzadCfzth4ST-u3FWnM9nxWqrKpMd_Howr-R9UoQ1wlVGy_4Bsc1FogM-ALxwBYTjeCuOz-cgmyvy_Wc9nIQEUN0UqC3KJ7pdhOIWT4kZ7uuZ15IryiFXlMuKuTFVsZ3HZ3Qh9J5OyYH3NdVmvrs4G1FiNP1d6m77Iv9-sq4Ywlxfnhd6TB-Hdcu6rNkh_U64J7aRnKoLIIBltUNXGB-nFEZhgbi0vHWpTt66i0hMH2oyQ1SK1ZpO_IzJBwaOHZTmTsnx4Nh8CF8NxKKOdeo7Kt99OXmbDfvYpGi0nk2hxulrcQXcdWDTIehYfVo3DDyiGqmZd83g6ngtu8_7gTfY0leOreAuDJqurnRxajvzuVXv8o5AeD9sLFfCwo7YsHqIHer2Bw5o8j1BH5I_Rvan2qHiCJopDGDiEDYew4RCuOYRbDuF1jg2HcFngGBsOYcmhp2g5Ol0Mx7ausGFzkMXUFh4nmQcDNMn8gKag2wvixp7wvTQQzKNc9FOYAAcBddOMU068JBCZn7pJkvpxQAbP0FFe5OIFwgImBof0U1DAM5rwLCEOj_vczTw3gTW8sBA1_2bEdfp5WQXlMlLLUEaiFgT47kQ1CBbqNd2u6vwrf-twsgdV08sBXdxlg4GF3hrsIhClcn8szkVRbWWuXFmhEi5toec1lm1vVSeCMQt5eyg3P5Bp2vfP5Otzla5d5dBjroWcPT5EdaDzn9_m5S0e9hW63w7N1-iovK7EG9CUy-REDYBf73e2qQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IRF-1+and+miRNA126+modulate+VCAM-1+expression+in+response+to+a+high-fat+meal&rft.jtitle=Circulation+research&rft.au=Sun%2C+Chongxiu&rft.au=Alkhoury%2C+Kenan&rft.au=Wang%2C+Ying+I&rft.au=Foster%2C+Greg+A&rft.date=2012-09-28&rft.issn=1524-4571&rft.eissn=1524-4571&rft.volume=111&rft.issue=8&rft.spage=1054&rft_id=info:doi/10.1161%2FCIRCRESAHA.112.270314&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon